Pharma design teams sit between two pressures. Brand managers want speed and consistency across markets. Medical, Legal, and Regulatory reviewers want every asset to hold up under scrutiny. Somewhere in the middle sits a design system that theoretically enforces both, until a designer overrides a colour token at 4pm on a Friday and nobody catches it before submission.
This is the gap custom Figma plugins close. A Figma plugin is a small piece of software that runs inside Figma itself. It can read your file, scan components against rules, apply changes, generate assets, or connect to external systems. The Promedia team builds custom plugins because generic ones cannot encode pharma-specific rules, and because the European Accessibility Act now makes those rules legally enforceable.
A useful plugin starts with a repeatable rule, not a wish list. If your team corrects the same footnote structure across every asset, that is a plugin. If designers guess at approved colour tokens across four brand variants, that is a plugin. If accessibility contrast fails only get caught in MLR, that is definitely a plugin.
Three ingredients make the build possible:
Promedia's AI Design System philosophy treats plugins and AI agents as the layer that handles repetitive work: brand integration, accessibility checks, documentation, token maintenance. What that layer protects is brand consistency, WCAG compliance, and design system integrity, enforced automatically every time a designer touches a file.
Manual WCAG audits take weeks. Automated scanners run externally after the fact and, according to recent accessibility research, catch only around a quarter to a third of WCAG issues on their own. That leaves the majority of failures either invisible until user testing or exposed after launch, which is exactly when penalties under the EAA start to apply.
A plugin that lives inside Figma changes the timing. Promedia's WCAG Compliance Plugin, scans the design system library and checks every component against WCAG 2.2, then generates a prioritized fix report in minutes rather than weeks. Because the check happens at the component level before any asset leaves the design phase, MLR receives files that are already accessible, not files that need remediation cycles.
This matters for the MLR process itself. Review cycles fail less often because the content is wrong and more often because the process around it was wrong from the start. Building compliance into the asset before submission, rather than correcting it after, reduces review rounds, compliance flags, and approval time. A plugin is simply the mechanism that makes that possible at scale.
Brand token drift is one of the most expensive silent problems in pharma design. A slightly-off blue on a patient brochure looks like nothing until it appears next to the correct blue on a congress booth. Multiply that across 15 markets, four agencies of record, and three production partners, and consistency becomes impossible to enforce by memo.
A custom plugin scans every component against approved tokens and flags any deviation before the file is exported. The same plugin can enforce HCP versus patient content flags, regulatory footnote structures, and multi-market brand variants. Generic AI-powered plugins like FigmaLint can audit components for general compliance, but they cannot recognize that a specific hex value is off-brand for a specific therapeutic area in a specific market. That knowledge has to be encoded by a team that understands pharma.
Promedia's AI-Assisted Brand Integration Plugin takes this further. Combined with an AI agent, it parses any brand PDF and generates a complete, compliant design system ready to import into Figma, roughly 70 to 80% faster than manual integration. Break-even lands after about eight brands, with pure savings after that. Everything runs inside the client's Figma environment with no data leaving.
Figma's collaborative environment lets multiple designers and reviewers work on a single live file simultaneously, which eliminates the version conflicts that used to slow multi-market rollouts. What Figma does not solve on its own is the enforcement of market-specific rules: which claims are approved where, which footnotes apply, which colour variants belong to which affiliate.
A plugin layer handles that. The same file can serve 15 markets when the plugin checks each variant against its market-specific rule set at export. Designers stop maintaining mental maps of what is allowed where. Reviewers stop finding the same three errors on every affiliate submission.
The plugin is not the point. Consistency at scale is. The plugin is just the enforcement mechanism that makes consistency cheaper than inconsistency.
A Figma plugin is a small piece of software that runs inside Figma and can read files, scan components, apply changes, or connect to external systems. For regulated industries like pharma, plugins encode specific rules, approved tokens, accessibility standards, regulatory footnote structures, and enforce them automatically at the design stage rather than during review.
Yes. A custom plugin can scan every component in a design system against WCAG 2.2 AA contrast requirements and generate a prioritized fix report. Promedia's WCAG Compliance Plugin does this in minutes, replacing manual audits that used to take weeks and catching failures before MLR ever sees the file.
The reliable approach is to enforce brand rules at the component level inside Figma, using a plugin that checks tokens, variants, and market-specific rules on every file. Manual review across 15 markets and multiple agencies does not scale. Automated enforcement inside the design tool does.
If your team spends hours per week on the same corrections, that is your first plugin. Start with a rule that is deterministic, painful, and repeated. Build against a test file that reflects real production mess, not a tidy demo. Use the Figma Plugin API and either an in-house developer or a partner who understands both the API and the regulatory context.
The teams that get this right treat plugins as infrastructure, not tools. They protect the design system the same way IT protects the network, automatically, every time, without asking the designer to remember. That is where consistency at scale actually comes from.
If you are considering a custom plugin for your pharma design system, Promedia has built and maintained several in production. A short conversation is usually enough to identify whether the problem is worth automating.
One short email when we publish. No spam, no sales pitch. Unsubscribe whenever.
